Abeona Therapeutics (ABEO) Capital Leases (2019)
Abeona Therapeutics' (ABEO) quarterly Capital Leases came in at $6.7 million in Q2 2019, down 3.16% quarter-over-quarter from $6.9 million in Q1 2019.
Abeona Therapeutics (ABEO) Capital Leases (2019) Analysis & Trends
Abeona Therapeutics' Capital Leases history runs 1 years deep, the most recent figure standing at $6.7 million for Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 6.71 Mn |
| Mar 31, 2019 | 6.93 Mn |